Clinical Obstetrics
Poster Session 4
Natav Hendin, MD
The Sackler Faculty of Medicine, Tel-Aviv University
Tel Aviv, Israel, Israel
Michal Grosvald, CNM
Rabin Medical Center
HaMerkaz, Israel, Israel
Ilana Shemesh, CNM
Rabin Medical Center
HaMerkaz, Israel, Israel
Adi Borovich, MD,MPH
Rabin Medical Center
Tel Aviv, HaMerkaz, Israel
Rony Chen, MD
Rabin medical center, Israel
Petach-Tikva, HaMerkaz, Israel
Eran Hadar, Prof.
Rabin Medical Center
Petach-Tikva, HaMerkaz, Israel
Ohad Houri, MD (he/him/his)
Doctor
Rabin Medical Center
Tel Aviv, Israel, Israel
The two groups were similar in their baseline characteristics. No significant differences were observed between the intervention and control groups regarding the duration of the third stage of labor (10.56 minutes ± 6.12 vs. 10.95 ± 6.33, p=0.65), the incidence of PPH (3.84% vs. 7.41%, p=0.38) or the amount of bleeding during the third stage of labor (292 grams ± 200 vs. 300 ± 242, p=0.79).
Furthermore, no significant differences were observed in the amount of bleeding in a subgroup analysis for nulliparity (356 ± 246 vs. 330 ± 240, p=0.68), multiparity (265 ± 171 vs. 289 ± 244, p=0.50), women who received oxytocin during labor (296 ± 198 vs. 289 ± 238, p=0.39) or not (287 ± 204 vs. 317 ± 250, p=0.59).
Conclusion: Placental drainage during the third stage of labor offers no benefit on third-stage length, PPH incidence or maternal blood loss.